You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data ⊕

found 2025 › Nov › 12 (Wed) @ 16:50 UTC

Healthy ■■
Novo Nordisk ■■
Novo ■■
Nordisk ■■
Trump ■■■■

Novo Nordisk released new data to underscore its pill's safety and effectiveness, while Trump is asked whether private plans could see lower GLP-1 costs.